This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

Canadian Risky Business: Why Fair and Predictable Patentable Utility is Critical to Investments and Innovation

Abstract

Investment in innovation and procurement of patent protection within any jurisdiction is justified by reliance upon fair and predictable patent protection. For new investment within any particular jurisdiction, innovators expect that historically well-settled legal doctrine pertaining to patents that conform to international norms and treaty obligations will remain consistent over time. Applicants also expect that countries will not “move the goalpost” of patentability requirements at some point after patent filing. Innovators have therefore been generally welcoming of patent harmonization which supports efficient and predictable patent protection in the multitude of jurisdictions in which they seek protection. Harmonization is predicated on the concept that an applicant can file a single application which will meet the patentability requirements of most major jurisdictions. Whether an invention relates to a life-changing new medicine or a mechanical device, it is required to possess utility for patentability. Indeed, as one of the most fundamental requirements in patent law, nearly major every jurisdiction excludes from patentability applications for inventions that lack patentable utility. As such, inventors must disclose a practical utility for their inventions upon filing their applications.

Author

Arvie Anderson
Assistant General Patent Counsel, Eli Lilly and Company, USA

Arvie Anderson is Assistant General Patent Counsel for Eli Lilly and Company where he has responsibility for litigation in a number of jurisdictions including Canada. He has been an attorney with Lilly for 15 years.

Company

Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

Related Papers

Patent Strategies for Attenuated Pathogen Vaccines
Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more
Portrait image of David Dolberg
David Dolberg
Senior Director of Intellectual Property, Sanaria Inc., USA
Ways to Avoid Having your Patents Cellected*
The Court of Appeals for the Federal Circuit caused frustrations when it decided to affirm the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are...Read more
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Portrait image of Michelle E. O'Brien
Michelle E. O'Brien
Partner, Marbury Law Group, USA
Section 112 Requirements for Life Sciences Patents
35 U.S.C. §112(a) of the US Patent Act is one of the integral parts of the quid pro quo patent system that balances the benefit of disclosure of the invention...Read more
Portrait image of Anagha Tendulkar
Anagha Tendulkar
In-house Patent Counsel, Cipla, India
A Current Look at the State of Inequitable Conduct and Other Equitable Concerns
Inequitable conduct is an “equitable defense to patent infringement that, if proved, bars enforcement of a patent. ” Therasense, Inc. v. Becton, Dickinson & Co. , 649 F. 3d 1276,...Read more
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Portrait image of Stacy Lewis
Stacy Lewis
Law Clerk, Finnegan, USA
Portrait image of Jordan Cowger
Jordan Cowger
Finnegan, USA
Portrait image of Melissa Santos
Melissa Santos
Finnegan, USA